From the Sector

Intertextile Shanghai Home Textiles – Spring Edition is set for a renewal. After last year’s brief pause, 283 exhibitors from 5 countries and regions will showcase their latest innovations at the National Exhibition and Convention Center (Shanghai) during this traditional peak sourcing period. The fair will be held concurrently with Intertextile Shanghai Apparel Fabrics – Spring Edition, Yarn Expo Spring, CHIC and PH Value from 28 – 30 March 2023.

Comprehensive range of products zoned for easy sourcing
The 27,000 sqm gross exhibition space in hall 5.2 will host suppliers in multiple product categories, such as bedding, towelling, table and kitchen linen, home textile technologies, and textile designs. Several product pavilions and zones will be formed to encourage efficient sourcing, with areas designated for quality bedding, towelling, feather and down duvet fillings, quilt fillings, intelligent equipment and upholstery fabric products. Buyers looking for sustainable fibres, yarns and fabrics may be interested in sourcing at the Lenzing Group’s brand new centralised Lenzing Home Textile Satellite Pavilion. With Lenzing joined by eight of its Chinese downstream manufacturers, the pavilion will showcase the various home textile applications for the Austrian company’s wood-based TENCEL™ fibres.

Other well-known international and domestic exhibitors include Cotton Council International (CCI), Zhangjiagang Coolist Life Technology, Guangdong Kulida Down, Wujiang City Yunjie Textiles, Yantai Pacific Home Fashion, Sunvim Group, and Jiangsu Goostars Hometextiles. These suppliers, and many more, will present their up-to-date products to meet the sourcing demands of buyers from different channels.

Programme
At every edition, Intertextile Shanghai Home Textile’s fringe events keep fairgoers informed on a variety of topics, allowing exhibitors and visitors alike to stay up to date with the latest market trends and make informed business decisions.

Aligning with the fair’s general direction on promoting sustainability, and to satisfy the industry’s needs, representatives from Lenzing will be holding an exclusive seminar about the e-commerce opportunities surrounding eco-friendly TENCEL™ products’ sleep enhancing qualities. Other presentations and discussions that touch on sustainability will also be available under the fair’s Textile & Technology event theme.

With consumers globally paying more attention to health issues and increasing their spending on health products, the home and contract textile industry is also a party to this rising trend. To this end, seminars discussing traditional Chinese medicine and how it relates to different health issues will be held on day one. Their crossover topics include how aromatherapy can encourage high-quality sleep, as well as an introduction on the innovation of traditional medicinal textiles.

Moreover, the well-known Chinese retailer JD.com will co-host an event that promotes home textile products made with Chinese cotton. Several talks will focus on different aspects, such as the products’ quality and the overall potential of this industry aided by government policies.

After China’s relaxation of border restrictions and other pandemic control measures, it is now easier for domestic and overseas buyers to visit their Chinese suppliers at the fairground, for the chance to touch and feel their desired products.

• Harmful PFAS chemicals, used in thousands of consumer products, are shaping up to be the big environmental and health threat of our time. The EU is now the first in the world to propose a broad ban on these chemicals.
• Consumer brands worth more than €130 billion support the ban on PFAS.  
• Investors with assets in PFAS-producing companies are calling for an end to production.

Many companies are taking a stand against PFAS chemicals as the EU invites the public to give its opinions on the proposed ban on these harmful chemicals.

108 companies dedicated to phasing out PFAS chemicals from products and processes have joined the PFAS Movement, an advocacy campaign initiated by environmental NGO ChemSec that calls for comprehensive regulation of PFAS in the EU. The members comprise many well-known brands, such as Inditex, Urbanears and the Cookware Company, representing various industries— fashion, home goods, food, and personal care. The members are worth more than €130 billion in total revenue.

“A European ban on PFAS chemicals will have huge repercussions for all manufacturing industries and require much work for companies in the global supply chain. However, some parts of the industry oppose this ban, claiming that the change is too big to be justified. That’s why the support for a ban from such influential consumer brands as those in the PFAS Movement is so important. It’s a strong sign that businesses want to eliminate PFAS chemicals in products and processes”, says Anne-Sofie Bäckar, Executive Director at ChemSec.

A Hollywood Helping Hand
ChemSec’s PFAS Movement is not only supported by the brands but also by Hollywood actor Mark Ruffalo who became a PFAS activist after his involvement in the film Dark Waters. The film depicts the real-life events following the massive uncovering of PFAS contamination in the USA. As a result, several PFAS producers in the USA are now involved in multimillion-dollar lawsuits.

The health and environmental threats of PFAS, along with all the lawsuits, have also created attention among another influential group: institutional investors. Last year, 47 institutional investors with US$8 trillion in assets sent a letter to 54 chemical companies named by ChemSec, calling for them to halt the production of persistent “forever chemicals”.

The EU ban on PFAS
The proposed EU ban on PFAS is extensive and the first of its kind worldwide. The idea was initially initiated by Sweden, Denmark, the Netherlands, Germany and Norway, who have spent almost three years mapping the implications of a ban on PFAS chemicals in a dossier that expands over nearly 2000 pages. The proposal shows, among other things, that the emissions of PFAS were 75 000 tonnes in 2020. If this continues, the emissions are expected to sit at 4.4 million tonnes in 30 years. The emissions originate from the production and use of the many products that contain PFAS; furniture, cosmetics, electronics and many more.

Alchemie Technology is the latest company to join the British Textile Machinery Association (BTMA), as all of the organisation’s members gear up to showcase an array of new innovations at ITMA 2023 in Milan from June 8-14 this year.

Cambridge-headquartered Alchemie is the inventor of two technologies – EndeavourTM and NovaraTM.

The Endeavour digital dyeing system produces no wastewater and reduces water consumption by up to 95% compared to traditional dyeing. The virtually waterless process delivers dyed fabric with high colour consistency and colour fastness and does not require post dyeing washing steps which leads to an energy reduction up to 85%. It can deliver any colour shade required and enables on-demand digital colour changeovers in any run length, from a few metres to several kilometres.

Similar energy savings can be achieved with the Novara precision finishing system which utilises a nozzle array to deliver finishing chemistry with millimetre resolution. Finishing chemistries penetrate deeply into the fabric due to the combination of high velocity liquid jetting and precisely-controlled vacuum and textile finishes are applied only where needed, reducing chemistry usage and enabling multi-functionality.

In the past year, Alchemie, backed by Swedish fashion giant H&M, has established a first demonstration hub at customer JSRTEX in Taiwan. It is now progressing plans to set up further centres at customer sites around the world.

Indorama Ventures Public Company Limited (IVL) reported a record FY22 financial performance from the company’s global manufacturing footprint serving end-consumers’ resilient need for daily necessities. The unusually high level of customer destocking that weighed on the fourth quarter result is expected to have leveled out and business should return to normal operating conditions, with China’s reopening to further spur demand.

Full-year Core EBITDA climbed 31% YoY to $2.3 billion as revenue rose 28% to a record $18.8 billion. The company recorded strong cash flows of $2.2 billion, up 111% YoY. Indorama Ventures’ geographically diversified, integrated platform, backed by management’s agility, withstood unprecedented global events to generate earnings through the business cycle. During the year, the company continued to focus on its growth plan, successfully integrating its strategic surfactants business in Latin America and Vietnamese packaging acquisition. A dedicated senior team is working tirelessly and is committed to the company’s ‘Vision 2030’ sustainability goals including recycling technologies and introducing biomass feedstock to the company’s product portfolio. The ongoing ‘Project Olympus’ cost transformation program delivered an annual run rate of $449 million in efficiencies.

The annual result was impacted by an unusually challenging final quarter as fears of a recession and reduced transit times led to widespread destocking by customers. 4Q22 Core EBITDA declined 43% YoY to $264 million on a 1% drop in revenue to $3.9 billion. The pandemic lockdown in China also continued into the final quarter, reducing factory demand across Indorama Ventures’ portfolio and resulting in narrower margins from lower prices and higher costs. Higher energy and utility costs impacted European operations as the war in Ukraine continued into the winter.

To improve competitiveness and build resilience, Indorama Ventures rationalized underperforming assets in the Fibers business in Europe and a PTA site in Asia, resulting in a $7 million cash impairment in 4Q22 and a $253 million non-cash impact. As a result, the company looks forward to a $38 million uplift in EBITDA in 2023, reaching up to $65 million by 2025.

Textile waste is a problem in Europe. Out of 7-7.5 million tonnes of textiles discarded every year, 30-35 % are collected separately – and of that quantity, 15-20 % are sorted by medium and larger sorting facilities within the EU. After sorting, 60 % still qualify as wearable clothes, however after a second or third collection-loop, all of the textiles become non-wearable sooner or later. Therefore, fibre-to-fibre recycling is becoming increasingly important to preserve the valuable resources.
 
The textile recycling value chain is not yet mature, but we are on the verge of a turning point, as different fibre-recycling technologies are deployed on a large scale. If successful, the textile recycling industry could reach a recycling rate of 18 to 26 percent of gross textile waste in 2030. This would create economic, social and environmental value that could total 3.5 to 4.5 billion euros in 2030.

Today, there is a sorting gap to achieve a circular economy for textiles in Europe. To feed this new circular value chain, a significant sorting-capacity increase is needed with 150 to 250 sorting and recycling facilities nearby, as the McKinsey-study “turning waste into value” assessed.

There is also a technology and capacity gap in sorting for reuse and recycling to ensure that high quality raw materials from non-wearable textile waste can be made available on a large scale. This is why the “Transform Textile Waste into Feedstock” project was initiated by TEXAID, within the ReHubs initiative together with well-known stakeholders of the textile value chain.

The major outcome of this project will be a sorting-factory blueprint fulfilling the requirements to the future needs of fibre-to-fibre recycling, enabling the future of more sustainable textiles by using recycled fibres. TEXAID, who is leading the project, is committed to build and operate scalable sorting facilities across Europe, the first with a capacity of 50,000 tonnes by the end of 2024.

Companies like Concordia, CuRe Technology, Decathlon, Inditex, Indorama Ventures, L’Atelier des Matières, Lenzing, Marchi & Fildi, PurFi, Södra, Worn Again and others are taking part in the project to jointly evaluate technologies and the business case for scaled sorting for reuse and recycling. ITA Academy GmbH (in cooperation with RWTH Aachen) together with CETIA has been commissioned for the assessment of technologies. The outcome will be an innovative sorting system 4.0, building on cross-functional technologies with digitalization and automation are at the heart.

• Sales of CHF 890.3 million in second half-year 2022
• EBIT margin of around 2% expected for full year 2022
• Order intake of CHF 1 157.3 million in 2022; order backlog of around CHF 1 540 million as of December 31, 2022
• Preparations for ITMA 2023 on schedule
• Implementation of action plan to increase sales and profitability ongoing
• Rieter site sales process on schedule

For Rieter, in addition to the geopolitical uncertainties, the 2022 financial year was characterized by three main challenges:
Due to the rapid rise in inflation, the exceptionally high order backlog of around CHF 1 840 million at the beginning of 2022 was processed at significantly higher costs. It was only possible to offset these higher costs in part by means of price increases and other remedial measures.

In order to safeguard deliveries, it was necessary to compensate for serious material bottlenecks, particularly in electronic components, which resulted in considerable additional development expenditure.

Major expenses were also incurred in connection with the acquired businesses (Accotex, Temco and Winder).

Sales
The realization of sales from the exceptionally high order backlog developed better than expected. With sales of CHF 1 510.9 million, Rieter achieved an increase of 56% compared with the previous year (2021: CHF 969.2 million). In the second half of 2022, especially in the fourth quarter, the measures introduced to address material bottlenecks had a positive impact. Consequently, sales increased to CHF 890.3 million compared with the first six months (first half-year 2022: CHF 620.6 million).

EBIT margin
The trend in the EBIT margin was strongly influenced by substantial cost increases, which could only be offset in part through price increases and other remedial measures. In addition, to compensate for material shortages, expenses were incurred in connection with the development of alternative solutions and the acquired businesses.

Rieter succeeded in improving profitability compared with the first half of 2022 due to the higher sales volume and offsetting measures to compensate for increased costs, and expects a positive EBIT margin of around 2% for the full year 2022 (2021: 4.9%).

Order intake
In line with expectations, the order intake of CHF 1 157.3 million in 2022 was below the record year of 2021 (CHF 2 225.7 million). The market situation is characterized by investment restraint due to geopolitical uncertainties, higher financing costs and consumer reticence in important markets.

Order backlog
The company had an order backlog of around CHF 1 540 million at the end of 2022, which thus extends well into 2023 and 2024. In 2022, Rieter recorded order cancellations of less than 10% of the order backlog of CHF 1 840 million at the beginning of the year.

Preparations for ITMA 2023 on schedule
Rieter has continued to boost its innovative capability and, in order to further extend its technology leadership, will present new innovative solutions at ITMA 2023 in Milan.

Action plan to increase sales and profitability
Implementation of the action plan to increase sales and profitability is ongoing. With regard to the profitability of the order backlog, which remains high, the implemented price increases in combination with a favorable trend in costs, particularly in logistics, are having an impact. In addition, progress was made in eliminating material bottlenecks and reducing expenses for the three acquired businesses.

Rieter site sales process
The sales process for the remaining land at the Rieter site in Winterthur (Switzerland) is proceeding according to plan. In total, around 75 000 m² of land will be sold. The Rieter CAMPUS is not part of this transaction.

Results press conference 2023
Rieter will provide further details on the 2022 financial year and an outlook for the 2023 financial year on March 9, 2023.

Der Bundesverband Medizintechnologie (BVMed) hat die heutige Entscheidung des Europäischen Parlament zu Änderungen an der EU-Medizinprodukte-Verordnung (MDR) begrüßt, fordert gleichzeitig aber auch Schritte, um das europäische Marktzugangssystem strategisch weiterzuentwickeln und im weltweiten Wettbewerb insbesondere um Innovationen besser aufzustellen. „Es ist ein gutes Signal für die medizinische Versorgung der Patient:innen und den Medizinprodukte-Standort Europa, dass Kommission, Rat und Parlament in den letzten Wochen Tempo gemacht und die notwendigen Änderungen im Schnellverfahren beschlossen haben“, so BVMed-Geschäftsführer und Vorstandsmitglied Dr. Marc-Pierre Möll.

Zum Hintergrund: Die Medizintechnik-Branche bereitet sich seit Jahren intensiv auf die MDR vor. Die Kosten der Umsetzung für die Branche werden nach Schätzungen zwischen 7 und 10 Milliarden Euro liegen. Die Branche hat massiv investiert, beispielsweise in zusätzliches regulatorisches Personal. Das MDR-System ist aber nach wie vor nicht praxistauglich. Zentrales Problem bei der MDR-Implementierung sind die Kapazitätsengpässe bei den Benannten Stellen sowie die sehr aufwendigen Zertifizierungsverfahren.  

Zur Vermeidung von Engpässen bei Medizinprodukten haben Parlament, Rat und Kommission nun unter anderem die Abschaffung der Abverkaufsfrist und eine Verlängerung der Übergangsfrist für die neuen Vorschriften nach einem risikobasierten Ansatz beschlossen. Außerdem werden Klasse III-Sonderanfertigungen mit in die Fristenverlängerung aufgenommen.

Parallel zu dieser wichtigen Maßnahme zur Entzerrung des Flaschenhals bei der Zertifizierung der Bestandsprodukte müssen nach Ansicht der BVMed auch die untergesetzlichen Maßnahmen, die von der Medical Device Coordination Group (MDCG) Ende August 2022 veröffentlicht wurden, pragmatisch umgesetzt werden, damit Bestandsprodukte zeitnah in die MDR überführt werden können und auch in Zukunft der Gesundheitsversorgung zur Verfügung stehen.

Mittelfristig geht es dem deutschen Medizintechnik-Verband darum, dass die MDR strategisch weiterentwickelt werden muss, damit Europa im schärfer werdenden Innovationswettbewerb gegenüber USA und Asien nicht weiter an Boden verliert. Der Beschluss der Schweiz, künftig auch die FDA-Zulassung des US-Systems zuzulassen, verdeutliche die Gefahr, dass das EU-System mit der MDR den Innovationswettbewerb der Zukunft verliere.

BVMed-Geschäftsführer Dr. Marc-Pierre Möll: „Wenn wir mehr und mehr Forschung und Entwicklung durch Abwanderung verlieren, dann verlieren wir damit nicht nur viele kluge Köpfe, sondern künftig auch Produktion und Wertschöpfung in Europa. Wir müssen deshalb jetzt daran arbeiten, die Rolle Europas als attraktive Region für Investitionen in medizintechnische Innovationen wieder zu stärken. Mit unserem innovationsstarken Mittelstand haben wir dafür die besten Voraussetzungen.“

Svegea of Sweden – a member of TMAS, the Swedish Textile Machinery Association – has recently installed an EC300-S collarette cutter for the high speed production of tubular apparel components as well as an FA350 automatic roll slitter at the plant of Löffler, in Ried im Innkreis, Austria.

The EC 300-S collarette cutter is equipped with the computer-controlled True-Drive II and high pre-feed device, which is used by garment manufacturers around the world for the production of tubular apparel components such as cuff and neck tapes and other seam reinforcements. It operates at speeds of up to 20,000 metres per hour. The integrated, fully automatic FA350 roll slitter FA500 roll slitter is equipped with three separately adjustable settings enabling three different band widths to be cut within the same cutting cycle. Automatic tube sewing units are provided for sewn tubes in optional rolled or flat folded forms, depending on customer preference.

Sports and knitwear specialist Löffler is celebrating its 50th anniversary in 2023. Its plant in Ried houses 25 circular knitting machines and three seamless knitting machines with an annual output of around 905,000 square metres of fabric, and in addition to product development, design, cutting and some sewing are all carried out in-house.

Löffler is known for its transtex under garments, which ushered in the two-layer principle of structures combining hydrophobic polypropylene and other fibres like cotton, Modal, Tencel or merino wool.

Before transtex, endurance athletes usually wore pure cotton underwear next to their skin, which became wet over time and cooled the body down. Löffler’s two-layer fabric prevented this, since the polypropylene does not absorb moisture and instead wicks it to the outside, where it can evaporate to keep the skin dry.

Innovation has been ongoing ever since, and in December, Löffler received an ISPO Award 2022 for transtex Retr’x – its latest functional underwear made from recycled polypropylene from textile waste and a combination of recycled and GOTS-certified organic cotton. Transtex Retr’x is neither dyed or bleached and is Standard 100 by Oeko-Tex as well as Made In Green by Oeko-Tex approved.

In addition to its own branded products, the plant makes sports garments for sister company Fischer, which is also based in Ried, and is at the same time involved in significant government tender projects, including the supply of polo shirts for the Austrian Red Cross and for the German and Austrian police forces. Combined, Löffler and Fischer employ approximately 700 people in the region of Upper Austria.

Global leading companies from more than 15 countries in the filtration and separation industry will connect with some 1,500 industry professionals and launch their innovations at FiltXPO™ 2023, Oct. 10-12, at Navy Pier in Chicago, Illinois.

FiltXPO™, an exhibition and conference dedicated exclusively to filtration and separation, is now being held on an 18-month cycle, making it a valuable opportunity to generate new business and grow global relationships with unique exposure to the North American market, according to INDA.

FiltXPO™ will draw senior-level professionals from around the world in major market segments involved in the design, manufacture, sales, and use of filtration/separation products and services.

A feature of the event will be the technical conference – Summit for Global Change. Five panels of global industry experts will debate filtration and separation’s most compelling challenges such as indoor air quality, filtration sustainability, standards and technologies. FiltXPO™ will also offer a one-and-a-half day intensive training course on the development, testing and application of filtration and separation media.

In der im Frühjahr 2022 gestarteten Datenbank „BVData“ des Bundesverbandes Medizintechnologie (BVMed) sind mittlerweile über 400 Bewertungsverfahren für über 200 innovative Untersuchungs- und Behandlungsmethoden mit Medizintechnologien abgebildet. Die BVMed-Datenbank bereitet aus der Medizintechnik-Perspektive die Methodenbewertungs-Verfahren des Gemeinsamen Bundesausschusses (G-BA) und weiterer beteiligter Organisationen strukturiert auf.

Die Anforderungen an die sichere und leistungsfähige Behandlung von Patient:innen mit Medizinprodukten wachsen stetig. Mit geeigneten Datenquellen können wichtige Erkenntnisse aus dem Versorgungsalltag gewonnen werden, um die Behandlungsqualität zu verbessern. Ein wichtiges Instrument für Medizintechnik-Hersteller, um den Nutzen von Medizinprodukten zu belegen, sind Verfahren der Methodenbewertung, beispielsweise die Erprobungsverfahren.

Ein Methodenverfahren erfordert die Teilnahme vieler unabhängiger Institute. Hier ist allerdings die Kommunikation der Untersuchungsergebnisse und Beschlüsse nicht einheitlich geregelt. Einen vollständigen Überblick über die Methodenbewertung und Analysen gibt die herstellerorientierte digitale Bewertungsverfahren-Datenbank „BVData“ des BVMed. Dort werden Verfahren von der Eröffnung bis zur abschließenden Bewertung strukturiert hinterlegt. Mit den vollständig recherchierbaren Datensätzen zur Erprobung und Bewertung von Medizinprodukten können Medizintechnik-Unternehmen alle Daten schnell und aussagekräftig analysieren.